121 related articles for article (PubMed ID: 27903997)
1. Effects of Omega-3 Fatty Acid Supplementation on Serum Biomarkers, Inflammatory Agents, and Quality of Life of Patients on Hemodialysis.
Moeinzadeh F; Shahidi S; Mortazavi M; Dolatkhah S; Kajbaf M; Haghjooy Javanmard S; Moghtaderi A
Iran J Kidney Dis; 2016 Nov; 10(6):381-387. PubMed ID: 27903997
[TBL] [Abstract][Full Text] [Related]
2. Potential Effects of Omega-3 Fatty Acids on Insulin Resistance and Lipid Profile in Maintenance Hemodialysis Patients: a Randomized Placebo-Controlled Trial.
Gharekhani A; Dashti-Khavidaki S; Lessan-Pezeshki M; Khatami MR
Iran J Kidney Dis; 2016 Sep; 10(5):310-318. PubMed ID: 27721230
[TBL] [Abstract][Full Text] [Related]
3. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
Singh S; Arora RR; Singh M; Khosla S
Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
[TBL] [Abstract][Full Text] [Related]
4. Effects of omega-3 fatty acid plus alpha-tocopherol supplementation on malnutrition-inflammation score, biomarkers of inflammation and oxidative stress in chronic hemodialysis patients.
Asemi Z; Soleimani A; Shakeri H; Mazroii N; Esmaillzadeh A
Int Urol Nephrol; 2016 Nov; 48(11):1887-1895. PubMed ID: 27554670
[TBL] [Abstract][Full Text] [Related]
5. Effects of omega-3 fatty acids on serum lipids, lipoprotein (a), and hematologic factors in hemodialysis patients.
Kooshki A; Taleban FA; Tabibi H; Hedayati M
Ren Fail; 2011; 33(9):892-8. PubMed ID: 21859401
[TBL] [Abstract][Full Text] [Related]
6. The benefits of ω-3 supplementation depend on adiponectin basal level and adiponectin increase after the supplementation: A randomized clinical trial.
Barbosa MM; Melo AL; Damasceno NR
Nutrition; 2017 Feb; 34():7-13. PubMed ID: 28063515
[TBL] [Abstract][Full Text] [Related]
7. Effects of protein and omega-3 supplementation, provided during regular dialysis sessions, on nutritional and inflammatory indices in hemodialysis patients.
Daud ZA; Tubie B; Adams J; Quainton T; Osia R; Tubie S; Kaur D; Khosla P; Sheyman M
Vasc Health Risk Manag; 2012; 8():187-95. PubMed ID: 22536073
[TBL] [Abstract][Full Text] [Related]
8. Effect of Omega-3 Fatty Acids on Serum Lipid Profile and Oxidative Stress in Pediatric Patients on Regular Hemodialysis: A Randomized Placebo-Controlled Study.
Ateya AM; Sabri NA; El Hakim I; Shaheen SM
J Ren Nutr; 2017 May; 27(3):169-174. PubMed ID: 28110812
[TBL] [Abstract][Full Text] [Related]
9. Effects of oral supplementation with omega-3 fatty acids on nutritional state and inflammatory markers in maintenance hemodialysis patients.
Gharekhani A; Khatami MR; Dashti-Khavidaki S; Razeghi E; Abdollahi A; Hashemi-Nazari SS; Mansournia MA
J Ren Nutr; 2014 May; 24(3):177-85. PubMed ID: 24613294
[TBL] [Abstract][Full Text] [Related]
10. Effect of treatment with omega-3 fatty acids on C-reactive protein and tumor necrosis factor-alfa in hemodialysis patients.
Tayyebi-Khosroshahi H; Houshyar J; Dehgan-Hesari R; Alikhah H; Vatankhah AM; Safaeian AR; Zonouz NR
Saudi J Kidney Dis Transpl; 2012 May; 23(3):500-6. PubMed ID: 22569435
[TBL] [Abstract][Full Text] [Related]
11. Effect of eicosapentaenoic/docosahexaenoic fatty acids and soluble fibers on blood lipids of individuals classified into different levels of lipidemia.
Castro IA; Monteiro VC; Barroso LP; Bertolami MC
Nutrition; 2007 Feb; 23(2):127-37. PubMed ID: 17234506
[TBL] [Abstract][Full Text] [Related]
12. Effects of Flaxseed Oil on Serum Lipids and Lipoproteins in Hemodialysis Patients: a Randomized Controlled Trial.
Mirfatahi M; Tabibi H; Nasrollahi A; Hedayati M
Iran J Kidney Dis; 2016 Nov; 10(6):405-412. PubMed ID: 27904000
[TBL] [Abstract][Full Text] [Related]
13. Effect of omega-3 supplementation on serum level of homocysteine in hemodialysis patients.
Tayebi-Khosroshahi H; Dehgan R; Habibi Asl B; Safaian A; Panahi F; Estakhri R; Purasgar B
Iran J Kidney Dis; 2013 Nov; 7(6):479-84. PubMed ID: 24241095
[TBL] [Abstract][Full Text] [Related]
14. A novel, multi-ingredient supplement to manage elevated blood lipids in patients with no evidence of cardiovascular disease: a pilot study.
Hobbs T; Caso R; McMahon D; Nymark M
Altern Ther Health Med; 2014; 20(5):18-23. PubMed ID: 25141367
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 fatty acid supplementation and total homocysteine levels in end-stage renal disease patients.
Beavers KM; Beavers DP; Bowden RG; Wilson RL; Gentile M
Nephrology (Carlton); 2008 Jun; 13(4):284-8. PubMed ID: 18331436
[TBL] [Abstract][Full Text] [Related]
16. Effects of omega-3 fatty acids on depression and quality of life in maintenance hemodialysis patients.
Dashti-Khavidaki S; Gharekhani A; Khatami MR; Miri ES; Khalili H; Razeghi E; Hashemi-Nazari SS; Mansournia MA
Am J Ther; 2014; 21(4):275-87. PubMed ID: 24987942
[TBL] [Abstract][Full Text] [Related]
17. Association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients.
Khatami MR; Mirchi E; Khazaeipour Z; Abdollahi A; Jahanmardi A
Iran J Kidney Dis; 2013 Jan; 7(1):47-52. PubMed ID: 23314142
[TBL] [Abstract][Full Text] [Related]
18. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects.
Kar S
Am J Ther; 2014; 21(1):56-66. PubMed ID: 21975796
[TBL] [Abstract][Full Text] [Related]
19. The impact of fish oil and wheat germ oil combination on mineral-bone and inflammatory markers in maintenance hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial.
Zakaria H; Mostafa TM; El-Azab GA; Abd El Wahab AM; Elshahawy H; Sayed-Ahmed NA
Int Urol Nephrol; 2017 Oct; 49(10):1851-1858. PubMed ID: 28667579
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Omega-3 Supplement on Serum Lipid Profile in Patients Undergoing Hemodialysis: A Randomized Clinical Trial.
Jabbari M; Khoshnevis T; Jenabi A; Yousefi F
Rom J Intern Med; 2016 Dec; 54(4):222-227. PubMed ID: 28002035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
